American Society of Hematology

SHERPA: Blue

People

  1. Horwitz
    Horwitz
  2. Moskowitz
    Moskowitz
  3. Moskowitz
    Moskowitz
  4. Levine
    Levine
  5. Matasar
    Matasar
  6. Palomba
    Palomba
  7. Sauter
    Sauter
  8. Gerecitano
    Gerecitano
  9. Hamlin
    Hamlin
  10. Noy
    Noy

Groups

  1. Center for Hematologic Malignancies (10)
  2. Department of Medicine (10)
  3. Hematologic Malignancies, Division of (10)
  4. Population Sciences Research Program (10)
  5. Lymphoma (9)
  6. Survivorship Research (5)
  7. Biostatistics Service (4)
  8. Epidemiology and Biostatistics (4)
  9. Executive Committee, Center for Hematologic Malignancies (4)
  10. Adult Leukemia (3)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Population Sciences Research Program"
  3. "Blood"
  4. "2015"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (10)
  2. Department of Medicine (10)
  3. Hematologic Malignancies, Division of (10)
  4. Population Sciences Research Program (10)
  5. Lymphoma (9)
  6. Survivorship Research (5)

More Groups

People
  1. Steven Horwitz (8)
  2. Alison Moskowitz (4)
  3. Craig Moskowitz (4)
  4. Craig Sauter (3)
  5. Maria Palomba (3)
  6. Matthew Matasar (3)

More People

Years
  1. 2015 (10)
Publications
  1. Blood (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Refractory T-cell prolymphocytic leukemia with JAK3 mutation: In vitro and clinical synergy of tofacitinib and ruxolitinib
    Meeting Abstract

    Wei, M.; Koshy, N.; van Besien, K.; Inghirami, G.; Horwitz, S. M.
    Blood (2015)

    Fulltext@MSK | Save
  • Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma
    Meeting Abstract

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Successful treatment of peripheral T-cell lymphoma with allogeneic stem cell transplantation: A large single-center experience
    Meeting Abstract

    Mehta-Shah, N.; Chou, J.; Maloy, M.; Zhang, Z. G.; Moskowitz, A. J.; Moskowitz, C. H.; Barker, J. N.; Giralt, S.; Perales, M. A.; Horwitz, S. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Results from a phase 1/2, open-label, dose-finding study of pralatrexate and oral bexarotene in patients with relapsed/refractory cutaneous T-cell lymphoma
    Meeting Abstract

    Duvic, M.; Horwitz, S. M.; Kim, Y. H.; Zinzani, P. L.; Bhat, G.; Sharma, P.; Yancik, S.
    Blood (2015)

    Fulltext@MSK | Save
  • Next-generation sequencing of matched normal blood identifies clonal hematopoiesis in a significant subset of solid tumor patients without hematologic malignancies
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Middha, S.; Cheng, D.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Frontline treatment of CD30+peripheral T-cell lymphomas with brentuximab vedotin in combination with CHP: 3-year durability and survival follow-up
    Meeting Abstract

    Horwitz, S. M.; Shustov, A. R.; Forero-Torres, A.; Bartlett, N. L.; Advani, R.; Pro, B.; Chen, R.; Davies, A. J.; Illidge, T.; Huebner, D.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • High-depth, targeted, next generation sequencing identifies novel genetic alterations in cutaneous T-cell lymphoma
    Meeting Abstract

    Argyropoulos, K. V.; Horwitz, S. M.; Rapaport, F.; Velardi, E.; Myskowski, P.; Querfeld, C.; Pulitzer, M.; Dogan, A.; Gallagher, M.; Socci, N. D.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • mTOR inhibition in T-cell lymphoma: A path(way) forward
    Journal Article

    Moskowitz, A. J.; Horwitz, S. M.
    Blood (2015)

    Fulltext@MSK | Save
  • R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
    Journal Article

    Omuro, A.; Correa, D. D.; Deangelis, L. M.; Moskowitz, C. H.; Matasar, M. J.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C. C.; more...
    Blood (2015)

    Fulltext@MSK | Save